SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-24-010746
Filing Date
2024-02-05
Accepted
2024-02-05 17:06:59
Documents
5
Group Members
NOVARTIS DATA42 AG

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm245237d1_sctoc.htm SC TO-C 28657
2 EXHIBIT 99.1 tm245237d1_ex99-1.htm EX-99.1 41476
3 EXHIBIT 99.2 tm245237d1_ex99-2.htm EX-99.2 17751
4 GRAPHIC tm245237d1_ex99-1img02.jpg GRAPHIC 4359
5 GRAPHIC tm245237d1_ex99-1img03.jpg GRAPHIC 4376
  Complete submission text file 0001104659-24-010746.txt   101924
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Subject) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90872 | Film No.: 24596687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)